Neil Thanedar
Angel Investor
Flint, United States
Neil Thanedar is a seed investor in Flint focused on Finance and Wellness. Neil Thanedar is the Founder and GP of Utopic Ventures and the Founder and Chairman of Labdoor and Air to All.Previously, Neil was the Founder and President of Avomeen Analytical Services, a chemical analysis and product development laboratory.He has also served as Senior Advisor to his father Shri Thanedar in his campaigns for Governor, StateRepresentative, and US Congress in Michigan.Neil graduated from the University of Michigan in 2010 with degrees in Molecular Biology and Business Administration.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 13%
Last updated:
For AI agents: llms.txt
Industries Neil Thanedar invests in
Stages Neil Thanedar invests in
Countries Neil Thanedar invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $125k–$10M
- Pre-Seed
- $125k–$190k
Investment Focus
Industry
- Finance 2 (25%)
- Wellness 2 (25%)
- Financial Services 2 (25%)
- Apps 1 (13%)
- Audio 1 (13%)
Stage
- Seed 5 (63%)
- Pre-Seed 2 (25%)
- Funding Round 1 (13%)
Country
- United States 4 (50%)
- Mexico 1 (13%)
- Nigeria 1 (13%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Biophysical Therapeutics uses computational biology to design new drugs. It has a pipeline of experimentally-validated new drugs. Its primary targets are cancer, diseases of aging (e.g., Alzheimer's disease), and aging itself. Also pursuing cosmetics. Has a record of discovering new fundamental biology. Owns [by granted patents] inventedpreclinical, and repurposed clinical, stage drugs. Company has and is prosecuting longevity drug candidates (drugs to slow, halt or reverse aging). A longevity company. Professor George Church (of Harvard Medical School) is an Advisor. Scientist founder, Dr. Michael Forrest, is a Cambridge University biochemistry graduate with a Ph.D. in computer science. | $190K / Pre-Seed / Jun 05, 2023 | ||
| Paystack lets businesses in Africa accept payments from anyone, anywhere in the world via credit card, debit card, money transfer, and mobile money on their websites or mobile apps. The platform offers easy-to-use features like linking bank accounts, sending money in a few steps, and saving recipients for quick payments. With Paystack, businessescan accept payments from customers anywhere in the world, enhancing their ability to grow and reach new markets. | $1.3M / Seed / Dec 19, 2016 | ||
| Beek is building the top audio platform in Latin America. 10/10 people you see on the streets with headphones, will be listening on Beek to the best audiobooks, podcasts, meditations, and any audio content that they like. There will be a Netflix for Spoken word audio for the 480M+ native Spanish Speakers, and Beek is the team building it. | $125K / Seed / Apr 25, 2016 | ||
| Sano is building a small, wearable sensor that can capture and transmit blood chemistry data continuously to virtually any device. The company will liberate this data to a third-party development and analytical platform called the API for the bloodstream. | $10.3M / Seed / Jun 19, 2015 | ||
| MatterFab offers a production 3D metal printer solution that removes the limitations of industrial fabrication. Final part production is the fastest growing segment of 3D printing built on equipment designed for prototyping that is not designed to scale. MatterFab provides a scalable production additive manufacturing solution with printers,material supply, traceable powder cartridges, training, education, maintenance services, and application engineering support to accelerate the adoption of additive manufacturing in our client's organizations. Manufacturing has the power to shape the world and MatterFab has the power to reshape manufacturing. | $7.5M / Seed / Sep 29, 2014 | ||
| Experiment is an online community and a crowdfunding platform for scientific research. It provides crowdfunding services for scientific research related to categories such as biology, chemistry, computer science, medicine, anthropology, psychology, engineering, and more.The platform provides its services for researchers from over 150institutions and universities around the world. It is in strategic partnerships with Experiment was founded by | $1.2M / Jun 01, 2013 | ||
| Labdoor is a testing lab that publicly verifies the quality of consumer products, starting with supplements. On Labdoor.com, consumers can find scientific product reviews and shop for hundreds of quality-tested supplements all in one place. They also offer a "Labdoor Certified" program to companies who submit every lot of their productsto us for quality control testing.From their chemistry lab in South San Francisco, Labdoor analyzes the purity and potency of popular products to find out which ones have what they claim and if they have any harmful ingredients or contaminants. Then, they grade and rank those products, write reports, and publish that information for free, so consumers can confidently buy the best supplements for their needs. | $250K / Seed / Jul 05, 2012 | ||
| See all 8 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Neil Thanedar invest in?
Neil Thanedar invests primarily in Finance, Wellness and Financial Services startups, most often at Seed and Pre-Seed stage. Most of the 8 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Neil Thanedar invest in?
Neil Thanedar typically joins rounds of $125k–$10M at Seed and $125k–$190k at Pre-Seed. These are whole funding-round sizes, not Neil Thanedar's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Neil Thanedar took part in.
How do I contact Neil Thanedar?
Public channels for Neil Thanedar include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Neil Thanedar last invest?
The most recent investment recorded for Neil Thanedar closed in Jun 2023. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
